MAL-family proteins overexpressed in tumor cells —for example, MAL2 in BRCA, PAAD, and UCEC, and MALL in PAAD—could serve as putative target antigens for CAR-T cell therapy. The gene discussed is MALL; the disease is pancreatic adenocarcinoma.